Ascendant Solutions, Inc. Reports Second Quarter 2009 Earnings, Earnings per Share and EBITDA.

DALLAS -- Ascendant Solutions, Inc. ("Ascendant" or the "Company") (Pink Sheets: ASDS) today announced its results for the second quarter of fiscal 2009. The Company reported a consolidated net loss of $55,000 for the fiscal quarter ended June 30, 2009, compared to net income of $1,671,000 in 2008, resulting in net loss per share ("EPS") of less than ($0.01) compared to net income per share of $0.07. Consolidated net income for the six months ended June 30, 2009 was $148,000, compared to $1,409,000 for the six months ended 2008, resulting in net EPS of $0.01 compared to $0.06. Results for 2008 include the $1,714,000 gain on sale of discontinued Medicine Man Pharmacies ("Med Man") operations, which the Company sold to Pharmacy Operations, Inc. on April 11, 2008.

For the fiscal quarter ended June 30, 2009, the Company reported Consolidated Earnings before Interest, Taxes, Depreciation and Amortization ("EBITDA") of $59,000 compared to consolidated EBITDA of $271,000 in the second quarter of 2008. EBITDA for the six months ended June 30, 2009, was $369,000 compared to ($3,000) for the same period of 2008. As noted below, EBITDA for all periods presented do not include the discontinued Med Man operations.

EBITDA is calculated as net income before deducting interest, taxes, depreciation and amortization and also does not include discontinued operations. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company's management reviews these non-GAAP financial measures internally to evaluate the Company's performance and manage the operations. Additionally, the Company believes it is a useful metric to evaluate operating performance and has therefore included such measures in the reporting of operating results.

Healthcare

The Company's subsidiary, Dougherty's Holdings, Inc. ("DHI"), which owns and operates Dougherty's Pharmacy and the discontinued Med Man operations, reported EBITDA of $345,000 for the second quarter of 2009, compared to $230,000 for the second quarter of 2008. EBITDA for the six month period ending June 30, 2009 was $760,000 compared to $531,000 for the same period of 2008.

EBITDA for the fiscal quarter ended June 30, 2008 does not include the discontinued Med Man operations, which the Company sold to Pharmacy Operations, Inc. on April 11, 2008. Net income from discontinued operations for the fiscal quarter and six months ended June 30, 2008 was $1,550,000 and $1,670,000, respectively.

Real Estate Advisory Services 

EBITDA for the fiscal quarter ended June 30, 2009 from the Company's real estate advisory services segment was $118,000 compared to $374,000 for the same period of 2008. EBITDA for the six months ended June 30, 2009 was $293,000 compared to $127,000 for the same period of 2008.

Corporate and Other

EBITDA for the fiscal quarter ended June 30, 2009 and 2008 from the corporate and other segment was ($404,000) and ($333,000), respectively. EBITDA for the six months ended June 30, 2009 and 2008 from the corporate and other segment was ($684,000) and ($661,000), respectively.

[TABLE OMITTED]
[TABLE OMITTED]

About Ascendant Solutions, Inc.

Ascendant Solutions, Inc. is a value oriented, investment firm concentrated on making equity investments in underperforming or distressed middle-market companies. Ascendant is primarily interested in investing in manufacturing, service, finance, retail and distribution businesses with $20 to $150 million in annual revenues that require access to capital or capital restructuring, and strategic support to improve operational performance. Ascendant currently has approximately $43 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Ascendant specializes in solving complex transactions where creative and quick solutions can add value to an enterprise.